Secrets of platelet exocytosis - what do we really know about platelet secretion mechanisms?

SummaryA critical aspect of hemostasis is the release of clot-forming components from the three intra-platelet stores: dense core granules, α-granules and lysosomes. Exocytosis from these granules is mediated by soluble (SNAPs and NSF) and integralmembrane proteins (v- and t-SNAREs).Three SM (Sec1/Munc18) proteins are present in mouse platelets (Munc18a, 18b and 18c) and each potentially regulates exocytosis via modulation of their cognate syntaxin binding partner. To define the molecular machinery required for platelet exocytosis, we analyzed platelets from Munc18c heterozygous knockout mice. These platelets show a decrease in Munc18c but no apparent reduction in other secretory machinery components. No differences in the rates of aggregation or of secretion of [3H]-5HT (dense core granules), platelet factor 4 (α-granules), or hexosaminidase (lysosomes) were detected between platelets from Munc18c heterozygous knockout or wild-type mice. The platelets also show normal morphology. Contrary to a predicted requirement for Munc18c in platelet secretion, data reported here show that reducing Munc18c levels does not substantially alter platelet function. These data show that despite Munc18c’s role in platelet secretion, the lack of a secretion defect may be attributed to compensation by other Munc18 isoforms or that one allele is sufficient to maintain secretion under standard conditions.

Download Full-text

Temporal Secretion of α-Granular Products: Insights into the Mechanisms of Release Reaction

Blood ◽

10.1182/blood.v120.21.sci-36.sci-36 ◽

2012 ◽

Vol 120 (21) ◽

pp. SCI-36-SCI-36

Author(s):

Sidney W. Whiteheart

Keyword(s):

Membrane Proteins ◽

Membrane Fusion ◽

Wound Repair ◽

Conflicts Of Interest ◽

Genetically Engineered ◽

Snare Complex ◽

Iκb Kinase ◽

Syntaxin 11 ◽

Platelet Exocytosis ◽

Platelet Secretion

Abstract Abstract SCI-36 Upon activation, platelets secrete numerous molecules that affect the local vascular microenvironment. Many of these components are important for hemostasis; however, others play key roles in the sequelae of thrombosis, such as angiogenesis, inflammation, and wound repair. These molecules are stored in three general types of platelet granules: dense, α, and lysosome. Analysis of platelet exocytosis shows that there is a direct correlation between agonist potency (thrombin > convulxin > PAR1 agonist > PAR4 agonist) and the extent and rate of content release. Release from dense granules is most rapid, while lysosome content release is the slowest; release of α-granule contents is heterogeneous. Detailed analysis of α-granule cargo release identified three kinetic classes of release events that differ in their rate. The content released in each of these three classes appeared to be random. Mechanistically, secretion from each granule requires integral membrane proteins called soluble NSF attachment protein receptors (SNAREs). v-SNAREs (vesicle-associated membrane proteins [VAMPs] from the granules) and heterodimeric t-SNAREs (syntaxins and SNAP-23 from the plasma membrane) form a trans-membrane, trimeric complex that mediates fusion and content release. How and where the SNAREs interact is controlled by regulatory proteins that in turn are affected during platelet activation. By analyzing platelet secretion from knockout mice and patients with familial hemophagocytic lymphohistiocytosis (FHL), it has been possible to identify the machinery required for each granule secretion event. Platelets contain four v-SNAREs (VAMP-2, −3, −7, and −8), but only VAMP-8 is required for content release. Platelets contain six t-SNAREs (syntaxin 2, 4, 7, 11, 13, and SNAP-23). Deletion of only syntaxin 11 in patients with FHL4 is sufficient to diminish platelet secretion. SNAP-23 is regulated by phosphorylation on Ser 95 by IκB kinase (IKK). This is important for SNARE complex formation, membrane fusion, and secretion. Intriguingly, mice treated with IKK inhibitors or genetically engineered with a platelet-specific deletion of Ikkb show increased tail-bleeding times. A number of syntaxin regulators have been identified in platelets. MUNC18b is a syntaxin 11 chaperone that is essential for platelet secretion in FHL5 patients. MUNC13 proteins, which facilitate t-SNARE/v-SNARE binding, are also important for platelet granule release. Deletion of Munc13-4 results in a significant platelet secretion defect and a robust bleeding diathesis in mice. Biochemical analysis shows that MUNC13-4 is a docking/tethering factor required to increase the efficacy of membrane fusion. Both MUNC18b and MUNC13-4 appear to be limiting in platelets, suggesting that they might be useful therapeutic targets. A greater understanding of platelet exocytosis is unfolding. This knowledge will undoubtedly lead to the development of better antithrombotic drugs. This work is supported by HL56652 and HL091893 from the National Institutes of Health. Disclosures: No relevant conflicts of interest to declare.

Download Full-text

Role of Munc13-4 as a Ca2+-dependent tether during platelet secretion

Biochemical Journal ◽

10.1042/bj20151150 ◽

2016 ◽

Vol 473 (5) ◽

pp. 627-639 ◽

Cited By ~ 18

Author(s):

Michael C. Chicka ◽

Qiansheng Ren ◽

David Richards ◽

Lance M. Hellman ◽

Jinchao Zhang ◽

...

Keyword(s):

Dense Granule ◽

Rapid Response ◽

Vascular Damage ◽

Dependent Manner ◽

Dense Granule Secretion ◽

Granule Secretion ◽

Platelet Exocytosis ◽

Platelet Secretion

Platelet exocytosis, mediated by SNAREs and Ca2+-dependent regulators, is critical for haemostasis. Munc13-4 binds membranes in a Ca2+- and phosphatidylserine (PS)-dependent manner and acts as a tethering factor for pre-docked platelet dense granule secretion to mediate rapid response to vascular damage.

Download Full-text

Platelet secretion is kinetically heterogeneous in an agonist-responsive manner

Blood ◽

10.1182/blood-2012-07-445080 ◽

2012 ◽

Vol 120 (26) ◽

pp. 5209-5216 ◽

Cited By ~ 117

Author(s):

Deepa Jonnalagadda ◽

Leighton T. Izu ◽

Sidney W. Whiteheart

Keyword(s):

Stochastic Process ◽

Time Course ◽

Specific Pattern ◽

Bioactive Molecules ◽

Release Time ◽

Wide Range ◽

Time Course Data ◽

Context Specific ◽

Platelet Exocytosis ◽

Platelet Secretion

Abstract Platelets release numerous bioactive molecules stored in their granules enabling them to exert a wide range of effects on the vascular microenvironment. Are these granule cargo released thematically in a context-specific pattern or via a stochastic, kinetically controlled process? Here we sought to describe the platelet exocytosis using a systematic examination of platelet secretion kinetics. Platelets were stimulated for increasing times with different agonists (ie, thrombin, PAR1-agonist, PAR4-agonist, and convulxin) and micro-ELISA arrays were used to quantify the release of 28 distinct α-granule cargo molecules. Agonist potency directly correlated with the speed and extent of release. PAR4-agonist induced slower release of fewer molecules, whereas thrombin rapidly induced the greatest release. Cargo with opposing actions (eg, proangiogenic and antiangiogenic) had similar release profiles, suggesting limited thematic response to specific agonists. From the release time-course data, rate constants were calculated and used to probe for underlying patterns. Probability density function and operator variance analyses were consistent with 3 classes of release events, differing in their rates. The distribution of cargo into these 3 classes was heterogeneous, suggesting that platelet secretion is a stochastic process potentially controlled by several factors, such as cargo solubility, granule shape, and/or granule-plasma membrane fusion routes.

Download Full-text

Munc18b/STXBP2 is required for platelet secretion

Blood ◽

10.1182/blood-2012-05-430629 ◽

2012 ◽

Vol 120 (12) ◽

pp. 2493-2500 ◽

Cited By ~ 60

Author(s):

Rania Al Hawas ◽

Qiansheng Ren ◽

Shaojing Ye ◽

Zubair A. Karim ◽

Alexandra H. Filipovich ◽

...

Keyword(s):

Human Platelets ◽

Limiting Factor ◽

Attachment Protein ◽

Platelet Factor ◽

Sensitive Factor ◽

Protein Receptors ◽

Heterozygous Patient ◽

Syntaxin 11 ◽

Platelet Exocytosis ◽

Platelet Secretion

Abstract Platelets are vital for hemostasis because they release their granule contents in response to vascular damage. Platelet exocytosis is mediated by soluble N-ethylmaleimide–sensitive factor attachment protein receptors (SNAREs), whose interactions are governed by regulators, eg, Sec/Munc18 proteins. These proteins chaperone syntaxin t-SNAREs and are required for exocytosis. Platelets contain 3 Munc18 isoforms: Munc18a, Munc18b, and Munc18c. We report that Munc18b is the major isoform and is required for platelet secretion. Familial hemophagocytic lymphohistiocytosis type 5 (FHL5) is caused by defects in the Munc18b/STXBP2 gene. We confirm a previous report showing that platelets from FHL5 patients have defective secretion. Serotonin, ADP/ATP, and platelet factor 4 release was profoundly affected in the 2 biallelic patients and partially in a heterozygous patient. Release of lysosomal contents was only affected in the biallelic platelets. Platelets from the FHL5 biallelic patients showed decreased Munc18b and syntaxin-11 levels were significantly reduced; other syntaxins were unaffected. Munc18b formed complexes with syntaxin-11, SNAP-23, and vesicle-associated membrane protein-8 in human platelets. Other potential secretion regulators, Munc13-4 and Rab27, were also found associated. These data demonstrate a key role for Munc18b, perhaps as a limiting factor, in platelet exocytosis and suggest that it regulates syntaxin-11.

Download Full-text

Syntaxin-11, but not syntaxin-2 or syntaxin-4, is required for platelet secretion

Blood ◽

10.1182/blood-2012-05-430603 ◽

2012 ◽

Vol 120 (12) ◽

pp. 2484-2492 ◽

Cited By ~ 63

Author(s):

Shaojing Ye ◽

Zubair A. Karim ◽

Rania Al Hawas ◽

Jeffery E. Pessin ◽

Alexandra H. Filipovich ◽

...

Keyword(s):

Plasma Membranes ◽

Critical Role ◽

Snare Proteins ◽

Mouse Strains ◽

Double Knockout ◽

Protein Receptor ◽

Syntaxin 4 ◽

Syntaxin 11 ◽

Platelet Exocytosis ◽

Platelet Secretion

Abstract The platelet release reaction plays a critical role in thrombosis and contributes to the events that follow hemostasis. Previous studies have shown that platelet secretion is mediated by Soluble NSF Attachment Protein Receptor (SNARE) proteins from granule and plasma membranes. The SNAREs form transmembrane complexes that mediate membrane fusion and granule cargo release. Although VAMP-8 (v-SNARE) and SNAP-23 (a t-SNARE class) are important for platelet secretion, the identity of the functional syntaxin (another t-SNARE class) has been controversial. Previous studies using anti-syntaxin Abs in permeabilized platelets have suggested roles for both syntaxin-2 and syntaxin-4. In the present study, we tested these conclusions using platelets from syntaxin-knockout mouse strains and from a Familial Hemophagocytic Lymphohistiocytosis type 4 (FHL4) patient. Platelets from syntaxin-2 and syntaxin-4 single- or double-knockout mice had no secretion defect. Platelets from a FHL4 patient deficient in syntaxin-11 had a robust defect in agonist-induced secretion although their morphology, activation, and cargo levels appeared normal. Semiquantitative Western blotting showed that syntaxin-11 is the more abundant syntaxin in both human and murine platelets. Coimmunoprecipitation experiments showed that syntaxin-11 can form SNARE complexes with both VAMP-8 and SNAP-23. The results of the present study indicate that syntaxin-11, but not syntaxin-2 or syntaxin-4, is required for platelet exocytosis.

Download Full-text

Deficiency of (33P)2MeS-ADP Binding Sites on Platelets with Secretion Defect, Normal Granule Stores and Normal Thromboxane A2 Production

Thrombosis and Haemostasis ◽

10.1055/s-0038-1656090 ◽

1997 ◽

Vol 77 (05) ◽

pp. 0986-0990 ◽

Cited By ~ 66

Author(s):

Marco Cattaneo ◽

Rossana Lombardi ◽

Maddalena L Zighetti ◽

Christian Gachet ◽

Philippe Ohlmann ◽

...

Keyword(s):

Binding Sites ◽

Specific Binding ◽

Thromboxane A2 ◽

Normal Subjects ◽

Congenital Defects ◽

Normal Production ◽

Adp Receptor ◽

Partial Deficiency ◽

Induced Aggregation ◽

Platelet Secretion

SummaryBy the term “Primary Secretion Defect” (PSD), we mean a common heterogeneous group of congenital defects of platelet secretion, characterized by a normal primary wave of platelet aggregation induced by ADP and other agonists, a normal concentration of platelet granule contents, and normal production of thromboxane A2. The biochemical abnormalities responsible for PSD are not well known. Since a secretion defect similar to PSD is found in platelets that are severely deficient of binding sites for the ADP analogue 2MeS-ADP and do not aggregate in response to ADP, we tested the hypothesis that PSD platelets have moderately decreased 2MeS-ADP binding sites, which may be sufficient for normal ADP-induced aggregation but not for potentiating platelet secretion. The specific binding of [33P]2MeS-ADP to platelets from 3 PSD patients (347,443 and 490 sites/platelet; KD 2.8-3.9 nM) was lower than to platelets from 24 normal subjects (647 [530-1102]; KD = 3.8 [2.3-7.3]) (median [range]). Normal values were found in a fourth PSD patient (710; KD 3.7). The degree of inhibition of PGE1- induced cAMP increase by 0.1 |μM ADP was lower in patients than in controls. The secretion induced by the endoperoxide analogue U46619 from normal, acetylsalicylic acid-treated platelets under conditions that prevented the formation of large aggregates was potentiated by 1 fimol/1 ADP and inhibited by apyrase. These findings indicate that a partial deficiency of the platelet ADP receptor(s) might be responsible for the defect of platelet secretion in some PSD patients and that ADP potentiates platelet secretion independently of the formation of large aggregates and thromboxane A2 production.

Download Full-text

Faculty Opinions recommendation of A novel role for platelet secretion in angiogenesis: mediating bone marrow-derived cell mobilization and homing.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.11184957.12166055 ◽

2011 ◽

Author(s):

Xiaoping Du ◽

Kelly O'Brien

Keyword(s):

Bone Marrow ◽

Cell Mobilization ◽

Platelet Secretion

Download Full-text

Distinct Roles for Rap1b Protein in Platelet Secretion and Integrin αIIbβ3Outside-in Signaling

Journal of Biological Chemistry ◽

10.1074/jbc.m111.239608 ◽

2011 ◽

Vol 286 (45) ◽

pp. 39466-39477 ◽

Cited By ~ 51

Author(s):

Guoying Zhang ◽

Binggang Xiang ◽

Shaojing Ye ◽

Magdalena Chrzanowska-Wodnicka ◽

Andrew J. Morris ◽

...

Keyword(s):

Platelet Secretion

Download Full-text

Activation of stimulus-specific serine esterases (proteases) in the initiation of platelet secretion. I. Demonstration with organophosphorus inhibitors.

Journal of Experimental Medicine ◽

10.1084/jem.144.6.1657 ◽

1976 ◽

Vol 144 (6) ◽

pp. 1657-1673 ◽

Cited By ~ 11

Author(s):

P M Henson ◽

D Gould ◽

E L Becker

Keyword(s):

Serine Proteases ◽

Platelet Activating Factor ◽

Secretory Process ◽

Subsequent Reaction ◽

Irreversible Inhibitors ◽

Activity Structure ◽

Organophosphorus Inhibitors ◽

Rabbit Platelets ◽

Serine Esterases ◽

Platelet Secretion

The effect of organophosphorus inhibitors of serine esterases (proteases) on secretion from washed rabbit platelets was examined. Five noncytotoxic stimuli were employed: collagen, thrombin, heterologous anti-platelet antibody (in the absence of complement), rabbit C3 bound to zymosan, and platelet activating factor derived from antigen-stimulated, IgE-sensitized rabbit basophils. Diisoprophyl phosphofluoridate, three series of p-nitrophenyl ethyl phosphonates, and a series of cyclohexyl phenylalkylphosphonofluridates were all found to be inhibitory to the platelet secretion. These are irreversible inhibitors of serine proteases but in this system were only inhibitory if added to the platelets concurrently with the stimuli. Pretreatment of either the platelets or the stimuli with the inhibitors followed by washing, was without effect on the subsequent reaction. This suggested the involvement of stimulus-activatable serine proteases in the secretory process. The concept was supported by finding that nonphosphorylating phosphonates or hydrolyzed phosphonates or phosphonofluoridates were without inhibitory action. The effect of a series of phosphonates or phosphonoflouridates in inhibiting each stimulus exhibited a unique activity-structure profile. The demonstration of such unique profiles with four series of inhibitors for each of the five stimuli was interpreted as demonstrating that a specific activatable serine protease was involved in the platelet secretory response to each stimulus.

Download Full-text